RxDoctor Payments Data

Lucas Schnaidt, MD

Ophthalmology · Aberdeen, SDNPI 1477114098

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,428 of the $4,450 with a category attached, or 77.0%. 17 manufacturers reported payments, led by Alcon at 50.0% of the total. 2025 is the largest year on record at $1,979, more than ten times the $113 reported in 2020.

$4,450in general payments, 2019–2025

Across 72 payments — averaging $61.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • AbbVie$495
  • Amgen$481
  • Glaukos Corporation$296
  • Johnson & Johnson Surgical Vision, Inc.$230
  • Galderma Laboratories, L.p.$146
  • plus $574 from 11 others

What the payments were for

  • Travel & lodging$92221%
  • Food & beverage$3,42877%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,450 in reported general payments places this provider in the 75th percentile of 52 ophthalmology providers in South Dakota.

See all ophthalmology providers in South Dakota

Medicare billing

Part B allowed, 2024
$396,616
Medicare patients
413
Services billed
3,964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketorolac Tromethamine103$4,323
Tobramycin-DexamethasoneTobramycin/Dexamethasone52$1,923
Brimonidine Tartrate12$1,134
Prednisolone Acetate16$684
Latanoprost57$639
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat22$479
ErythromycinErythromycin Base26$391
Timolol Maleate28$341

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Aberdeen

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →